ArticlePloS one2024

Afatinib or Bevacizumab in combination with Osimertinib efficiently control tumor development in orthotopic murine models of non-small lung cancer.

Ulrich Jarry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.